Polygenic Risk-based Detection of Subclinical Coronary Atherosclerosis and Intervention With Statin and Colchicine

NCT05850091 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Coronary Artery Disease

Interventions

DRUG: Rosuvastatin
DRUG: Colchicine
DRUG: Placebo

Sponsor

Massachusetts General Hospital

Collaborators

[object Object]